Tanning devices - Fast track to skin cancer?

January 15, 2004

An all over tan is fashionable and large numbers of people, especially young women, achieve this by using sunbeds. Professor Antony Young, of King's College London, has reviewed the evidence that links sunbed use to malignant melanoma; a skin cancer that is fatal if not detected and treated early. Malignant melanoma is a cancer of the skin's cells that are responsible for tanning (melanocytes). Unlike most cancers, that tend to occur in late middle age, malignant melanoma can appear in younger people. There are about 6000 new cases of malignant melanoma in the UK each year and it is the 3rd most common cancer in women under 35. New data published earlier this week shows that malignant melanoma in the UK has increased by 24% in the period 1995-2000.

The tanning properties of sunbeds come from their UVB and UVA radiation, both of which are found in the sun's ultraviolet rays. This radiation is known to damage the skin's genetic information and its immunity, and it is these effects that result in skin cancer. Tanning is increasingly recognized as the skin's SOS response to damage by ultraviolet radiation (UVR). It is often argued that a tan is protective but in reality a suntan is equivalent to a sunscreen with a very low sun protection factor (SPF) and its acquisition is associated with an accumulation of DNA damage.

Professor Young's review, in Pigment Cell Research, shows that there is increasingly compelling evidence for a link between sunbed use and malignant melanoma. This link is not surprising because the sun's UVR is widely recognized as the primary cause of malignant melanoma. The continuing and widespread use of sunbeds is likely to result in increased numbers of people with malignant melanoma. There is a good case, as is done in some countries, for restricting sunbed use to those of 18 years of age and above. It is also worth noting that the regular use of sunbeds will markedly accelerate skin ageing.
-end-


Blackwell Publishing Ltd.

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.